ePrivacy and GPDR Cookie Consent by Cookie Consent Fréquence médicale


Rédaction en Chef : Pr Patrice Darmon (Marseille) et Dr Louis Potier (Paris)



EASD 2019
Hypolipémiants, PCSK9 et risque de diabète
CONCLUDE: hypoglycaemia and HbA1c with degludec compared to glargine U300 in insulin-treated ...
REWIND Trial : Effect of dulaglutide on serious health outcomes
ADA 2019
24 Hours a Day Closed-Loop Insulin trial in ...
REWIND trial: Once-Weekly Dulaglutide and Major ...
CAROLINA Trial : Cardiovascular Outcomes Trial ...
Les derniers congrès
Paroles de patients
fiches patients